E Fund Management’s AnaptysBio ANAB Stock Holding History

E Fund Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	+3,083	New	+$187K	﹤0.01%	449

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

E Fund Management's ANAB Position: Q2 2026 in Review

E Fund Management opened a new position in AnaptysBio (ANAB) in Q2 2026: 3,083 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #449 among its holdings.

213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

E Fund Management held 3,083 shares of AnaptysBio worth $208K as of Q2 2026.
AnaptysBio was a new E Fund Management position in Q2 2026.
AnaptysBio made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #449 holding.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.